Bumper Offer - Urjas oil Just @ Rs. 1
S Vocita is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Depression. The alternative uses of S Vocita have also been explained below.
The correct dosage of S Vocita depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed S Vocita side effects, there are can be others also. These have been listed below. Such side effects of S Vocita normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, S Vocita's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on S Vocita related warnings talks about S Vocita's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the S Vocita contraindications section.
Additionally, S Vocita may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that S Vocita is not safe while driving, and is is not addictive in nature.
S Vocita is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when S Vocita is used -
Moderate
Mild
Is the use of S Vocita safe for pregnant women?
S Vocita can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking S Vocita right away. Take your doctor's advice before taking it again.
Is the use of S Vocita safe during breastfeeding?
Taking S Vocita may lead to serious side effects if you are breastfeeding. S Vocita should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of S Vocita on the Kidneys?
S Vocita rarely harms the kidneys.
What is the effect of S Vocita on the Liver?
S Vocita is rarely harmful for the liver.
What is the effect of S Vocita on the Heart?
S Vocita is rarely harmful for the heart.
S Vocita should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take S Vocita unless your doctor advises you to do so -
Is this S Vocita habit forming or addictive?
No, you will not get addicted to S Vocita.
Is it safe to drive or operate heavy machinery when consuming?
After taking S Vocita, you should not drive or work on any heavy machine, as S Vocita can make you drowsy.
Is it safe?
S Vocita should be used only after doctor's advice.
Is it able to treat mental disorders?
S Vocita has been seen to have positive effect on patients with mental disorders.
Interaction between Food and S Vocita
Taking S Vocita with food does not cause any problems.
Interaction between Alcohol and S Vocita
Consumption of alcohol and S Vocita together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522